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Purpose: To examine the association between physical activity, prevalence of hypertension, and total 
healthcare and pharmaceutical expenditure in the United States of America (US). 
Methods: In this cross-sectional study, adult United States residents were included from the Medical 
Expenditure Panel Survey (MEPS) for 2002. In the MEPS, physical activity was defined as spending at 
least 30 min 3 times a week in moderate to vigorous physical activity and the diagnosis of hypertension 
was based on the patient’s self-report. Logistic and multiple linear regression models were used to 
calculate the risk of prevalent hypertension in physically inactive individuals and examine the 
association between physical activity and healthcare expenditure after controlling for confounders.  
Results: Hypertensive patients who were physically active accounted for 46 % and the risk of 
hypertension was higher in physically inactive individuals than in those who were physically active 
(Odds ratio, 1.1; 95 % Confidence interval, 1.07 to 1.12, p < 0.0001). Physical activity in all individuals 
was associated with a decrease in total healthcare expenditure by US$592 per person (p < 0.0001) and 
pharmaceutical expenditure by US$125 per person (p < 0.0001).  
Conclusion: Total healthcare and pharmaceutical expenditures were significantly lower for physically 
active than physically inactive individuals.  
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INTRODUCTION 
 
Seven million deaths every year worldwide 
may be attributed to hypertension [1]. In the 
United States, about one in three adults have 
high blood pressure [2]. Hypertensive 
patients are at higher risk of myocardial 
infarction, heart failure, stroke, and kidney 
disease [1]. Blood pressure control in 
hypertensives is essential to prevent 
morbidity and mortality, reduce health care 
utilization, and ultimately lower health care 
costs [3]. Only 35 % of hypertensive patients 
have adequate blood pressure control [2]. In 
the United States, inadequate blood pressure 
control in hypertensive patients has been 
estimated to result in about 40,000 
cardiovascular events, more than 8,000 
cardiovascular deaths, and direct medical 
expenditure of one billion US dollars per year 
[4,5]. 
 
Randomized clinical trials have demonstrated 
that physical activity is associated with lower 
levels of blood pressure in both hypertensive 
and normotensive individuals [6-9]. Also, 
studies have shown that the relative risk of 
developing hypertension decreased in 
individuals who were physically active [10-
14]. Some of these studies were conducted 
outside the United States [12,14] and others 
did not provide a national estimate [10,11,13]. 
The current guidelines for the treatment of 
hypertension recommend that all patients 
with hypertension engage in physical activity 
for at least 30 min a day for most days of the 
week [1]. Physical activity lessens the effects 
of diseases, which includes hypertension, 
and the use of healthcare services. Studies 
that were previously undertaken to explore 
the effect of physical activity on health costs 
were small or did not provide a national 
estimate [15-18]. In the United States, 
antihypertensive medications account for 70 
to 80 % of the total cost of hypertension care 
[19]. The reduction in the use of these 
medications may lower total pharmaceutical 
expenditure. No studies have estimated the 
effect of physical activity on pharmaceutical 
expenditures. 
Using the Medical Expenditure Panel Survey 
(MEPS), the primary objectives of this study 
were the following: 1) obtain a national 
estimate for the risk of prevalent hypertension 
in physically inactive individuals compared to 
that in physically active individuals and 2) 
examine the association between physical 
activity and total healthcare and 
pharmaceutical expenditures for all 






MEPS was sponsored by the Agency for 
Healthcare Research and Quality (AHRQ) 
and provided the estimates of healthcare use, 
expenditures, sources of payment, and 
insurance coverage for individuals across the 
United States. The Household Component of 
MEPS for the year 2002 was used in this 
study. Individuals were included in the study 
if their age was 18 years or older and 
information was available about their physical 
activity. Since the data are available online 
anonymously, no ethical approval or patient 
consent was required.   
 
Dependent variables  
 
To estimate the risk of the prevalence of 
hypertension in physically inactive individuals 
compared with that in physically active 
individuals, a logistic regression model was 
generated using a diagnosis of hypertension 
as the dependent variable. To examine the 
association between physical activity and 
health expenditures, an ordinary least 
squares model was used. The dependent 
variables were the total healthcare 
expenditure or the pharmaceutical 
expenditure.  
 
In MEPS, the diagnosis of hypertension was 
based on the patient’s self-report. The total 
healthcare expenditure is the sum of direct 
payments for care provided during the year, 
including out-of-pocket payments and 
payments that were made by private 
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insurance, Medicaid, Medicare, and other 
sources. The total healthcare expenditures 
included expenses for office and hospital-
based care, emergency room visits, inpatient 
hospital stays, dental visits, home health 
care, prescribed medications, vision aids, and 
others. The total pharmaceutical expenditure 
is the sum of all of the amounts paid out-of-
pocket and by third-party payers for each 
prescription purchased in 2002. The total 
healthcare expenditure and the 
pharmaceutical expenditure were included as 
continuous variables. The logarithmic 
functional form of these continuous 
dependent variables was tested using the 
Bera-McAleer and Box-Cox tests, which did 
not fit the data better than the linear form. 
Therefore, the linear functional form for the 
dependent variables is reported.  
 
Key independent variable  
 
The key independent variable in this study 
was physical activity. In the survey, all 
individuals who were aged 18 years or more 
were asked whether they spent at least 30 
minutes in moderate to vigorous physical 




Several factors could affect the risk of 
developing hypertension, limitation of 
individuals from physical activity could affect 
the use of medications and access to care, or 
affect healthcare charges. On the basis of 
previous literature, these factors were 
included in the model [14,17]. The factors of 
interest were age, gender, race, insurance 
status (measured by whether or not the 
individual had any type of insurance), income 
(person’s total annual income was used), 
smoking status (individuals were asked 
whether they currently smoked), education 
(measured by the number of years of 
education), and body mass index (BMI). BMI 
was calculated on the basis of the reported 
weight and height.  
 
Individuals were asked if they had ever been 
diagnosed with diabetes, asthma, arthritis, 
high blood pressure, coronary heart disease, 
angina or angina pectoris, heart attack or 
myocardial infarction, any other type of heart 
disease or condition, or stroke or transient 
ischemic attack (TIA or ministroke). When the 
association between physical activity and 
health expenditures was examined, 
hypertension was included as an 
independent variable only when all of the 





The statistical software STATA (version 8, 
StataCorp LP, College Station, Texas) was 
used in the analysis. Several tests were used 
to examine the model assumptions and to 
test the significant of the independent 
variables that were included in the models. 
Multi-collinearity between the variables in the 
model was examined using a pairwise 
correlation. Cut-off values of < 0.3 were 
considered very low.  Correlation was very 
low between all variables, with the exception 
of a multicollinearity value of 0.48 between 
coronary heart disease and myocardial 
infarction. The variance inflation factors were 
examined. This examination revealed that 
none of the factors were higher than 10 (the 
highest was 1.59, and the average was 1.21). 
Therefore, collinearity was not a significant 
problem in these models.  
 
The MEPS used a complex survey design. 
Therefore, the analyses were adjusted for 
stratification, primary sampling units (PSUs), 
and weight before running the models. 
Individual weight, PSU, and strata for the 
year 2002 were used in the models whenever 
possible. When restricting the sample to 
hypertensive patients, no more than one PSU 
was found in each stratum, which will result in 
that the regression model could not run. 
Therefore, the data from hypertensive 
patients did not include stratification. Not 
controlling for stratification only increased the 
standard error of the estimate.  
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The odds ratio of having hypertension among 
physically inactive individuals was calculated 
using the logistic regression model. A 
complete-case analysis was used to analyze 
observations with missing data, which were 





In 2002, the prevalence of physical inactivity 
in the entire US population was 46.1 %. The 
characteristics of patients who were physical 
activity are presented in Table 1. Both groups 
are statistically different in all of the variables 
that were included. In hypertensive patients, 
only 45.6 % spent at least 30 min in 
moderate to vigorous physical activity at least 
three times a week. After controlling for other 
covariates in the model, the risk of 
hypertension was higher in those who were 
physically inactive compared with those who 
were physically active (Odds Ratio: 1.1, 95 % 
Confidence Interval: 1.07 to 1.12, p < 
0.0001).  
 
After controlling for covariates, physical 
activity in all individuals was associated with 
a decrease in the annual total healthcare 
expenditure of $592 US dollars (t = −6.06, p < 
0.0001) (Table 2) and in the pharmaceutical 
expenditure of $125 US dollars (t = − 6.15, p 
< 0.0001) (Table 3). As expected, the 
diagnosis of all diseases was associated with 
an increase in total healthcare and 
pharmaceutical expenditures (Table 3).  
 
In hypertensive patients, physical activity was 
associated with a statistically insignificant 
decrease in the total healthcare expenditure 
of $1011.30 US dollars (t = − 3.61, P = 0.069) 
(Table 4) and in the pharmaceutical 
expenditure of $195.80 US dollars (t = − 3.77, 




This is the first study in the United States to 
estimate the effect of physical activity on 
healthcare expenditures on a national level 
and to analyze the effect of physical activity 
on pharmaceutical expenditures. The 
participants who completed the MEPS were 
from different geographic areas and 
minorities, and this diversity increases the 
external validity and the generalizability of 
this study. The analyses controlled for factors  
 
Table 1: Weighted characteristics by physical 















Age (mean, yr)  43.9  47.3  
Gender (%) 






  White 
  African-American  










  Grades 0-8 
  Grades 9-12 
  College 











income (mean, $)  32,001  26,829  
Presence of insurance 
(%) 87.1 86.6 
BMI mean  26.3  27.9  
Smoking (%) 20.6 24 
Total health care 
expenditure ($) mean  
2,605  3,961  
Pharmaceutical 
expenditure ($) mean  
517  839  
Diagnosis (%) 
  CHD  
  Diabetes 
  Hypertension 
  Angina 
  Myocardial infarction 
  Other heart diseases 
  Stroke  
  Asthma 
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Table 2: Regression analysis of total health care 
expenditure in all individuals (sample = 22,826; 







active -591.86 97.65 <0.0001 
Age 31.26 3.99 <0.0001 
Female 592.33 98.84 <0.0001 
Race 
  White   
  Black 










Education 17.16 18.45 0.353 
Total 
individual 
income -.0038 .0018 0.038 
Holder of 
insurance 1435.01 81.44 <0.0001 
BMI -4.15 10.42 0.691 
Smoking -27.68 114.72 0.810 
Diagnosis 
  CHD 
  Diabetes 
  Hypertension 
  Angina 
  Myocardial 
infarction 
  Other heart 
diseases 
  Stroke 
  Asthma 





































Constant -759.81 354.62 0.033 
 
that could affect physical activity or 
expenditures. In the current study, it was 
found that less than 50 % of the US 
population exercise regularly. Our results 
show that physically active individuals are 
healthier than their physically inactive 
counterparts. African-Americans and other 
races had fewer expenditures compared with 
Caucasians. This finding may be attributed to 
differences in the access to care and the 
possible differences in behavior. 
 
Similar to previous studies [10-14], the 
current cross-sectional study demonstrated 
that the risk of hypertension was higher in 
those who were physically inactive compared 
with those who were physically active. 
Physical activity in all of the individuals was 
associated with significant decreases in the 
annual pharmaceutical and the total 
healthcare expenditures. Because the factors 
that could affect the physical activity or the 
expenditure were controlled in the analysis, 
the observed effect was attributed to the 
reduction in the use of medications and other 
healthcare services.  
 
The reduction that was identified in the 
healthcare expenditure confirmed the findings 
of  previous  studies  [15-17]. In  Canada,  
 
Table 3: Regression analysis of pharmaceutical 
expenditure in all individuals (sample = 22,826; 







active -125.02 20.32 <0.0001 
Age 6.70 .70 <0.0001 
Female 143.06 18.22 <0.0001 
Race 
  White   
  Black 













Education 8.068 3.28 0.015 
Total individual 
income -.0015 .0003 <0.0001 
Presence of 
insurance 201.81 17.69 <0.0001 
BMI 4.53 2.02 0.025 
Smoking 82.13 25.97 0.002 
Diagnosis  
  CHD 
  Diabetes 
  Hypertension 
  Angina 
  Myocardial 
infarction 
  Other heart 
diseases 
  Stroke 
  Asthma 





































Constant -387.06 81.21 <0.0001 
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Table 4: Regression analysis of total health care 
expenditure in hypertensive patients (sample = 









-1011.30 280.19 0.069 
Age 19.44 6.98 0.108 
Female 161.40 224.96 0.548 
Race 
  White   
  Black 

















-.01 .006 0.216 
Presence of 
insurance 2509.65 281.02 0.012 
BMI -35.03 31.22 0.378 
Smoking -296.49 167.73 0.219 
Diagnosis 
  CHD 
  Diabetes 
  Angina 
  Myocardial 
infarction 
  Other heart 
diseases 
  Stroke 
  Asthma 





































Constant 1191.98 1266.43 0.446 
 
 
approximately Can$2.1 billion (2.5 %) of the 
total direct healthcare costs were attributable 
to physical inactivity [16]. One cross-sectional 
study using the 1996 MEPS estimated that 
the direct medical expenditure of inactivity-
associated cardiovascular disease was 
US$23.7 billion [18]. However, the authors 
did not control for other covariates, and 
weighting was not applied to obtain a national 
estimate [18].  
 
In the current study, the physical activity of 
hypertensive patients was associated with a 
statistically insignificant decrease in the 
annual pharmaceutical and the total 
healthcare. The insignificant reduction is due 
to the high standard errors since the 
stratification design of the MEPS was not 
controlled for. 
 
Table 5: Regression analysis of pharmaceutical 
expenditure in hypertensive patients (sample = 









-195.80 51.95 0.064 
Age 7.60 .74 0.009 
Female 112.90 47.73 0.142 
Race 
  White   
  Black 

















-.0020 .00045 0.035 
Presence of 
insurance 432.30 103.13 0.052 
BMI 7.39 1.65 0.047 
Smoking 137.12 50.89 0.115 
Diagnosis 
  CHD 
  Diabetes 
  Angina 
  Myocardial 
infarction 
  Other heart 
diseases 
  Stroke 
  Asthma 





































Constant -236.46 64.95 0.068 
 
The current study has limitations that should 
be considered when interpreting the results. 
First, the cross-sectional design of this study 
makes it difficult to establish a causal 
relationship between hypertension and 
increase in physical activity. Therefore, this 
study shows just association between these 
factors. Second, favorable selection bias is a 
major threat to the current study. Patients 
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who exercise may be healthier compared 
with those who do not. Although several 
diseases that correlated with physical activity 
were included in the models, other variables 
were not included. Third, this study did not 
control for the stage of hypertension. This 
information about the disease stage was not 
available in the MEPS. Fourth, no information 
about the use of medications was collected to 
see if physical activity affected the dose or 
quantity of hypertensive medications used. 
Fifth, many variables in the MEPS, including 
physical activity, were self-reported by the 
individual. The effect of physical activity on 
blood pressure was also not assessed 
because blood pressure data is not available 
in the MEPS. Sixth, this study used MEPS 
database from the United States and the 
results may not be generalized 
internationally.  
The results of the current study should impact 
clinical practice and research. Healthcare 
professionals need to stress to their patients 
the importance of physical exercise in 
reducing the risk of hypertension and its 
complications. Health policy makers and 
insurance companies need to allocate 
resources for programs that encourage 
patients to exercise regularly. Future studies 
need to use a panel design to establish 
causal association and to control for the 




The prevalence of hypertension was high in 
physically inactive individuals. Total 
healthcare and pharmaceutical expenditures 
decreased in physically active individuals. 
Future studies with a follow-up design are 
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